“A risk factor in the development of hepatocellular carcinoma: Insulin analogues” (2022) Annals of Medical Research, 29(11), pp. 1209–1213. Available at: http://annalsmedres.org/index.php/aomr/article/view/4328 (Accessed: 5 April 2025).